SCHEMBL29475498

SCHEMBL29475498

COC(=O)c1cc(Cl)ccc1B(O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.59
NR4A2 P43354 2/20 0.55
SLC6A4 P31645 1/20 0.51
SLC6A3 Q01959 1/20 0.51
RXFP1 Q9HBX9 1/20 0.47
CHEK1 O14757 1/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 2/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HPGD P15428 1/20 0.45
LMNA P02545 3/20 0.45
PLA2G2A P14555 2/20 0.45
HCRTR1 O43613 1/20 0.44
HCRTR2 O43614 1/20 0.44
MAPT P10636 2/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
ALPL P05186 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17133623 1.00 ABL1 (0.59) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL29475502 1.00 ABL1 (0.59) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL16971638 0.87 ABL1 (0.62) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL6100118 0.82 ABL1 (0.70) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL26643257 0.81 CYP46A1 (0.55) NR4A2MEN1KMT2AKDM4EALDH1A1
SCHEMBL29957543 0.81 CA12 (0.65) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL3454367 0.81 CA12 (0.65) KDM4EALDH1A1SMN1; SMN2HPGDLMNA
SCHEMBL14829748 0.81 KDM4E (0.56) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL4363906 0.81 ABL1 (0.62) ABL1NR4A2SLC6A4SLC6A3RXFP1
SCHEMBL29952924 0.81 MAPK1 (0.51) MEN1KMT2AKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665715-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES Merck Patent GmbH (DE) 2025-12-24 EP disclosed
US-20250374826-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2025-12-04 US disclosed
WO-2024170605-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2024-08-22 WO disclosed
CN-113321659-B Organic electroluminescent material and device thereof 武汉尚赛光电科技有限公司 2023-04-18 CN disclosed
EP-4066289-A1 COMPOUNDS FOR ELECTRONIC DEVICES Merck Patent GmbH (DE) 2022-10-05 EP disclosed
CN-114730843-A Compounds for electronic devices 默克专利有限公司 2022-07-08 CN disclosed
WO-2022124499-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2022-06-16 WO disclosed
WO-2022039340-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME 엘티소재주식회사 2022-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250374826-A1 MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES INTS9, INSR, INF2 ABL1 25/4885NR4A2 2366/4885SLC6A4 3735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.